MedTrace Logo

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

NCT03949972 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-09-17

No results posted yet for this study

Summary

In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis (FSGS) over 10 years. The registry will provide a repository for biomaterials such as blood samples, DNA, urine, feces, and tissue biopsies that will be accessible to collaborators to facilitate future research on pathogenesis, diagnostics, and treatment.

Conditions

Interventions

OTHER

Biosampling

Biosampling at initial visit and follow-up visits

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER

  • Medical Faculty and the Faculty of Natural Sciences of the University of Cologne

    collaborator UNKNOWN

  • Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases

    collaborator UNKNOWN

  • Cologne Center for Genomics

    collaborator UNKNOWN

  • Prof. Dr. Paul Brinkkoetter

    lead OTHER

Principal Investigators

  • Paul T Brinkkoetter, MD · University Hospital of Cologne, Cologne, Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2028-03-31
Completion
2033-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03949972 on ClinicalTrials.gov